<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35105181</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1524-4628</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>53</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Stroke</Title>
          <ISOAbbreviation>Stroke</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Intracranial Large Artery Stenosis and Past Infectious Exposures: Results From the NOMAS Cohort.</ArticleTitle>
        <Pagination>
          <StartPage>1589</StartPage>
          <EndPage>1596</EndPage>
          <MedlinePgn>1589-1596</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1161/STROKEAHA.121.036793</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intracranial large artery stenosis (ILAS) is an important contributor to ischemic stroke in the United States and worldwide. There is evidence to suggest that chronic exposure to certain infectious agents may also be associated with ILAS. We aimed to study this association further in an ethnically diverse, prospective, population-based sample of Northern Manhattan.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled a random sample of stroke-free participants from an urban, racially, and ethnically diverse community in 1993. Participants have been followed prospectively and a subset underwent brain magnetic resonance angiograms from 2003 to 2008. Intracranial stenoses of the circle of Willis and vertebrobasilar arteries were scored as 0=no stenosis, 1≤50% (or luminal irregularities), 2=50% to 69%, 3≥70% stenosis, and 4=flow gap. We summed the individual score of each artery to produce a global ILAS score (possible range, 0-44). Past infectious exposure to <i>Chlamydia pneumoniae</i>, <i>Helicobacter pylori</i>, cytomegalovirus, and herpes simplex virus 1 and 2 was determined using serum antibody titers.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 572 NOMAS (Northern Manhattan Study) participants (mean age 71.0±8.0 years, 60% women, 68% Hispanic) with available magnetic resonance angiogram and serological data, herpes simplex virus 2 (beta=0.051, <i>P</i>&lt;0.001) and cytomegalovirus (beta=0.071, <i>P</i>&lt;0.05) were associated with ILAS score after adjusting for demographics and vascular risk factors. Stratifying by anterior and posterior circulations, herpes simplex virus 2 remained associated with the anterior circulation (beta=0.055 <i>P</i>&lt;0.01) but not with posterior circulation ILAS score.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Chronic infectious exposures, specifically herpes simplex virus 2 and cytomegalovirus were associated with asymptomatic ILAS as seen on magnetic resonance angiogram imaging. This may represent an additional target of intervention in the ongoing effort to stem the substantial global burden of strokes related to ILAS.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mehta</LastName>
            <ForeName>Amol</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-1343-7389</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Vagelos College of Physicians and Surgeons (A.M., M.S.V.E., J.G.), Mailman School of Public Health, Columbia University, New York, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khasiyev</LastName>
            <ForeName>Farid</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">0000-0002-3127-0973</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Saint Louis University, Saint Louis, MO (F.K.).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wright</LastName>
            <ForeName>Clinton B</ForeName>
            <Initials>CB</Initials>
            <Identifier Source="ORCID">0000-0002-9797-6215</Identifier>
            <AffiliationInfo>
              <Affiliation>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD (C.B.W.).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rundek</LastName>
            <ForeName>Tatjana</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">0000-0002-7115-9815</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology (T.R., R.L.S.), Miller School of Medicine, University of Miami, FL.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Public Health Sciences (T.R., R.L.S.), Miller School of Medicine, University of Miami, FL.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Evelyn F. McKnight Brain Institute (T.R., R.L.S.), Miller School of Medicine, University of Miami, FL.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sacco</LastName>
            <ForeName>Ralph L</ForeName>
            <Initials>RL</Initials>
            <Identifier Source="ORCID">0000-0003-4629-684X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology (T.R., R.L.S.), Miller School of Medicine, University of Miami, FL.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Public Health Sciences (T.R., R.L.S.), Miller School of Medicine, University of Miami, FL.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Evelyn F. McKnight Brain Institute (T.R., R.L.S.), Miller School of Medicine, University of Miami, FL.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Elkind</LastName>
            <ForeName>Mitchell S V</ForeName>
            <Initials>MSV</Initials>
            <Identifier Source="ORCID">0000-0003-2562-1156</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Vagelos College of Physicians and Surgeons (A.M., M.S.V.E., J.G.), Mailman School of Public Health, Columbia University, New York, NY.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology (M.S.V.E.), Mailman School of Public Health, Columbia University, New York, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gutierrez</LastName>
            <ForeName>Jose</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-2175-8078</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Vagelos College of Physicians and Surgeons (A.M., M.S.V.E., J.G.), Mailman School of Public Health, Columbia University, New York, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R56 NS029993</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R37 NS029993</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AG057709</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS029993</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS036286</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AG066162</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Stroke</MedlineTA>
        <NlmUniqueID>0235266</NlmUniqueID>
        <ISSNLinking>0039-2499</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001158" MajorTopicYN="N">Arteries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003251" MajorTopicYN="N">Constriction, Pathologic</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009625" MajorTopicYN="Y">Noma</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Helicobacter pylori</Keyword>
        <Keyword MajorTopicYN="N">cytomegalovirus</Keyword>
        <Keyword MajorTopicYN="N">infection</Keyword>
        <Keyword MajorTopicYN="N">ischemic stroke</Keyword>
        <Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>5</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>2</Day>
          <Hour>5</Hour>
          <Minute>28</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35105181</ArticleId>
        <ArticleId IdType="mid">NIHMS1770965</ArticleId>
        <ArticleId IdType="pmc">PMC9038664</ArticleId>
        <ArticleId IdType="doi">10.1161/STROKEAHA.121.036793</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: A large worldwide burden but a relatively neglected frontier. Stroke. 2008;39:2396–2399</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18535283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL. Ischemic stroke subtype incidence among whites, blacks, and hispanics: The northern manhattan study. Circulation. 2005;111:1327–1331</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15769776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qureshi AI, Safdar K, Patel M, Janssen RS, Frankel MR. Stroke in young black patients. Risk factors, subtypes, and prognosis. Stroke. 1995;26:1995–1998</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7482637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke. 2006;1:158–159</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18706036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The northern manhattan stroke study. Stroke. 1995;26:14–20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7839388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Resch JA, Baker AB. Etiologic mechanisms in cerebral atherosclerosis. Preliminary study of 3,839 cases. Arch Neurol. 1964;10:617–628</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14130420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rincon F, Sacco RL, Kranwinkel G, Xu Q, Paik MC, Boden-Albala B, Elkind MS. Incidence and risk factors of intracranial atherosclerotic stroke: The northern manhattan stroke study. Cerebrovasc Dis. 2009;28:65–71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2914420</ArticleId>
            <ArticleId IdType="pubmed">19468217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sangha RS, Naidech AM, Corado C, Ansari SA, Prabhakaran S. Challenges in the medical management of symptomatic intracranial stenosis in an urban setting. Stroke. 2017;48:2158–2163</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5558843</ArticleId>
            <ArticleId IdType="pubmed">28679857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yaghi S, Prabhakaran S, Khatri P, Liebeskind DS. Intracranial atherosclerotic disease. Stroke. 2019;50:1286–1293</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31009344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, et al.
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–1316</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15800226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA. 2002;288:2724–2731</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12460096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke. 1996;27:2207–2210</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8969782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: The west birmingham stroke project. Stroke. 1998;29:404–410</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9472881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkind MS, Tondella ML, Feikin DR, Fields BS, Homma S, Di Tullio MR. Seropositivity to chlamydia pneumoniae is associated with risk of first ischemic stroke. Stroke. 2006;37:790–795</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16424371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heuschmann PU, Neureiter D, Gesslein M, Craiovan B, Maass M, Faller G, Beck G, Neundoerfer B, Kolominsky-Rabas PL. Association between infection with helicobacter pylori and chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study. Stroke. 2001;32:2253–2258</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11588309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkind MS, Ramakrishnan P, Moon YP, Boden-Albala B, Liu KM, Spitalnik SL, Rundek T, Sacco RL, Paik MC. Infectious burden and risk of stroke: The northern manhattan study. Arch Neurol. 2010;67:33–38</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2830860</ArticleId>
            <ArticleId IdType="pubmed">19901154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: Emerging mechanistic paradigms. Circulation. 1999;100:e20–28</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10421626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, Morrison RP, Xu Q, Wick G. Cross-reactive b-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:1060–1065</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12702515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, Nelson JA. The human cytomegalovirus chemokine receptor us28 mediates vascular smooth muscle cell migration. Cell. 1999;99:511–520</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10589679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gredmark S, Britt WB, Xie X, Lindbom L, Soderberg-Naucler C. Human cytomegalovirus induces inhibition of macrophage differentiation by binding to human aminopeptidase n/cd13. J Immunol. 2004;173:4897–4907</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15470031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gredmark S, Tilburgs T, Soderberg-Naucler C. Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J Virol. 2004;78:10378–10389</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC516431</ArticleId>
            <ArticleId IdType="pubmed">15367604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, Epstein SE. Effects of total pathogen burden on coronary artery disease risk and c-reactive protein levels. Am J Cardiol. 2000;85:140–146</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10955367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strandberg TE, Pitkala KH, Linnavuori KH, Tilvis RS. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke. 2003;34:2126–2131</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12920256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkind MS, Luna JM, Moon YP, Boden-Albala B, Liu KM, Spitalnik S, Rundek T, Sacco RL, Paik MC. Infectious burden and carotid plaque thickness: The northern manhattan study. Stroke. 2010;41:e117–122</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2830875</ArticleId>
            <ArticleId IdType="pubmed">20075350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC. Homocysteine and the risk of ischemic stroke in a triethnic cohort: The northern manhattan study. Stroke. 2004;35:2263–2269</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15345803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, et al.
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3552515</ArticleId>
            <ArticleId IdType="pubmed">21899409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roth W, Morgello S, Goldman J, Mohr JP, Elkind MS, Marshall RS, Gutierrez J. Histopathological differences between the anterior and posterior brain arteries as a function of aging. Stroke. 2017;48:638–644</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5330785</ArticleId>
            <ArticleId IdType="pubmed">28196941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gutierrez J, Honig L, Elkind MS, Mohr JP, Goldman J, Dwork AJ, Morgello S, Marshall RS. Brain arterial aging and its relationship to alzheimer dementia. Neurology. 2016;86:1507–1515</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4836884</ArticleId>
            <ArticleId IdType="pubmed">26984942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Resch JA, Okabe N, Loewenson R, Kimoto K, Katsuki S, Baker AB. A comparative study of cerebral atherosclerosis in a japanese and minnesota population. J Atheroscler Res. 1967;7:687–693</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6052596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim JS, Nah HW, Park SM, Kim SK, Cho KH, Lee J, Lee YS, Kim J, Ha SW, Kim EG, et al.
Risk factors and stroke mechanisms in atherosclerotic stroke: Intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke. 2012;43:3313–3318</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23160885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gutierrez J, khasiyev F, Liu M, De Rosa J, Rundek T, Cheung CH, Wright C, Sacco R, Elkind M. Determinants and outcomes of asymptomatic intracranial atherosclerotic stenosis. J Am Coll Cardiol. 2021</Citation>
        </Reference>
        <Reference>
          <Citation>Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke : The northern manhattan stroke study. Stroke. 2000;31:1521–1525</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10884447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Esenwa CC, Elkind MS. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nat Rev Neurol. 2016;12:594–604</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27615422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grinde B
Herpesviruses: Latency and reactivation - viral strategies and host response. J Oral Microbiol. 2013;5</Citation>
        </Reference>
        <Reference>
          <Citation>Forbes HJ, Williamson E, Benjamin L, Breuer J, Brown MM, Langan SM, Minassian C, Smeeth L, Thomas SL, Warren-Gash C. Association of herpesviruses and stroke: Systematic review and meta-analysis. PLoS One. 2018;13:e0206163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6248930</ArticleId>
            <ArticleId IdType="pubmed">30462656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpesvirus-induced atherosclerosis in chickens. Fed Proc. 1983;42:2476–2479</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6840298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tulman ER, Afonso CL, Lu Z, Zsak L, Rock DL, Kutish GF. The genome of a very virulent marek’s disease virus. J Virol. 2000;74:7980–7988</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC112329</ArticleId>
            <ArticleId IdType="pubmed">10933706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu YP, Sun DD, Wang Y, Liu W, Yang J. Herpes simplex virus type 1 and type 2 infection increases atherosclerosis risk: Evidence based on a meta-analysis. Biomed Res Int. 2016;2016:2630865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4853930</ArticleId>
            <ArticleId IdType="pubmed">27195284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kis Z, Sas K, Gyulai Z, Treso B, Petrovay F, Kapusinszky B, Csire M, Endresz V, Burian K, Mandi Y, et al.
Chronic infections and genetic factors in the development of ischemic stroke. New Microbiol. 2007;30:213–220</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17802898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 1998;98:2796–2799</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9860778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burbelo PD, Hoshino Y, Leahy H, Krogmann T, Hornung RL, Iadarola MJ, Cohen JI. Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay. Clin Vaccine Immunol. 2009;16:366–371</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2650866</ArticleId>
            <ArticleId IdType="pubmed">19129469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Peng G, Bai J, He B, Huang K, Hu X, Liu D. Cytomegalovirus infection and relative risk of cardiovascular disease (ischemic heart disease, stroke, and cardiovascular death): A meta-analysis of prospective studies up to 2016. J Am Heart Assoc. 2017;6</Citation>
        </Reference>
        <Reference>
          <Citation>Blum A, Peleg A, Weinberg M. Anti-cytomegalovirus (cmv) igg antibody titer in patients with risk factors to atherosclerosis. Clin Exp Med. 2003;3:157–160</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14648230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee M, Baek H, Park JS, Kim S, Kyung C, Baik SJ, Lee BK, Kim JH, Ahn CW, Kim KR, et al.
Current helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study. PLoS One. 2018;13:e0193646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5834174</ArticleId>
            <ArticleId IdType="pubmed">29499055</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
